Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

(2017) K.C. Allen Chan et al.   NEW ENGLAND JOURNAL OF MEDICINE

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine

(2016) Michael W. Kattan et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories

(2016) Kristina R. Dahlstrom et al.   JOURNAL OF CLINICAL ONCOLOGY

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

(2016) Federico Rotolo et al.   JNCI-Journal of the National Cancer Institute

Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy

(2016) Hao Peng et al.   Scientific Reports

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

(2016) Federico Rotolo et al.   JNCI-Journal of the National Cancer Institute

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

(2015) Anne W.M. Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus–Related Oropharyngeal Carcinomas

(2015) Shao Hui Huang et al.   JOURNAL OF CLINICAL ONCOLOGY

Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials

(2015) Yu-Pei Chen et al.   RADIOTHERAPY AND ONCOLOGY

Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma

(2014) S. F. Leung et al.   ANNALS OF ONCOLOGY

Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of Nasopharyngeal Carcinoma Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area

(2014) Weihong Wei et al.   Oncology Research and Treatment

Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels

(2012) Wen-Yi Wang et al.   CANCER

Clinical significance of plasma Epstein–Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma

(2012) San Jiun Chai et al.   JOURNAL OF CLINICAL VIROLOGY

Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?

(2012) Rui Guo et al.   RADIOTHERAPY AND ONCOLOGY

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

(2010) W.-Y. Wang et al.   CLINICAL CANCER RESEARCH

Different Clinical Significance of Pre- and Post-treatment Plasma Epstein–Barr Virus DNA Load in Nasopharyngeal Carcinoma Treated with Radiotherapy

(2010) Xue Hou et al.   CLINICAL ONCOLOGY

Future of the TNM classification and staging system in head and neck cancer

(2010) Robert P. Takes et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore Experience

(2009) Ivan Weng-Keong Tham et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS